Diabetes Melitus sebagai Komorbiditas Utama terhadap Mortalitas Pasien COVID-19
DOI:
https://doi.org/10.29313/jrk.v3i2.3000Keywords:
COVID-19, Komorbiditas, MortalitasAbstract
Abstract. The purpose of this study was to analyze the relationship between comorbidities and mortality in COVID-19 patients. This study uses analytic methods with a cross-sectional research design. Data were obtained from the medical records of inpatients with confirmed COVID-19 at Al-Islam Hospital Bandung for the 2021 period. The statistical test used a univariate data test by looking at the characteristics of COVID-19 patients based on age, sex, and length of stay and using the Chi test -Square to analyze whether there is a relationship between the independent and dependent variables. The number of respondents in this study was 2,047 people, with the most age being ≥60 years (39.5%), male sex (51.3%), with the highest comorbidity diabetes mellitus (41.9%), followed by hypertension (35.7%) and renal disease (12.4%) which have CFR values of 10.1%, 5.9%, and 5.2% respectively. Patients with comorbid diseases have a decreased immune response and the location of ACE-2 receptors is found not only in the respiratory tract but also in other organs such as the pancreas and kidneys. The conclusion shows that there is a relationship between comorbidities and mortality of COVID-19 patients at Al-Islam Hospital Bandung in 2021 with a p-value <0.001 (p <0.05).
Abstrak. Tujuan penelitian ini adalah menganalisis hubungan komorbiditas dengan mortalitas pasien COVID-19. Penelitian ini menggunakan metode analitik dengan rancangan penelitian cross sectional. Data diperoleh dari rekam medis pasien rawat inap yang terkonfirmasi COVID-19 di Rumah Sakit Al-Islam Bandung Periode 2021. Uji Statistik menggunakan uji data univariat dengan melihat karakteristik pasien COVID-19 berdasarkan usia, jenis kelamin, dan lama rawat inap serta menggunakan uji Chi-Square untuk menganalisis ada tidaknya hubungan antara variable bebas dan terikat. Jumlah responden pada penelitian ini sebanyak 2.047 orang, dengan usia yang paling banyak ≥60 tahun (39,5%), jenis kelamin laki-laki (51,3%), dengan komorbiditas tertinggi diabetes melitus (41,9%), disusul dengan hipertensi (35,7%) dan renal disease (12,4%) yang memiliki nilai CFR berturut-turut 10,1%, 5,9%, dan 5,2%. Pasien dengan penyakit komorbid berada dalam penurunan respon imun serta lokasi reseptor ACE-2 yang ditemukan tidak hanya di saluran respirasi, tetapi juga didapatkan di organ lain seperti pankreas dan ginjal. Kesimpulan menunjukkan terdapat hubungan komorbiditas dengan mortalitas pasien COVID-19 di RS Al-Islam Bandung tahun 2021 dengan nilai p <0.001 (p<0.05).
References
Ejaz H, Alsrhani A, Zafar A, dkk. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020 Jul 28;13(7):1833 – 9.
Kesehatan K. Pedoman Pencegahan Dan Pengendalian Covid-19. Kementrian Kesehat [Internet]. 2020;5:178. Tersedia dari: https://covid19.go.id/p/protokol/pedoman-pencegahan-dan-pengendalian-coronavirus-disease-covid-19-revisi-ke-5
Who. WHO Coronavirus (COVID-19) Dashboard;2021. Tersedia dari: https://covid19.who.int
Hartati J, Damailia R, Trusda SAD. COVID-19 dan karakteristik patogenesis. Dalam: Respati T, Sulaiman Rathomi H, penyunting. KOPIDPEDIA – Bunga Rampai Artikel Penyakit Virus Korona COVID-19. Bandung: Pusat Penerbitan Universitas (P2U) Unisba; 2020. hlm. 13–23.
Alkautsar A. Hubungan Penyakit Komorbid dengan Tingkat Keparahan Pasien COVID-19. JMH. 2021 Okt;03(01):1488–93.
Kim DW, Byeon KH, Kim J, Cho KD, Lee N. The correlation of comorbidities on the mortality in patients with COVID-19: An observational study based on the Korean national health insurance big data. J Korean Med Sci. 2020 Jul 6;35(26):1 – 9.
Gold, M. S., Sehayek, D., Gabrielli, S., Zhang, X., McCusker, C., & Ben-Shoshan, M. (2020). COVID-19 and comorbidities: a systematic review and meta-analysis. Postgraduate Medicine, 749–755
Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, dkk. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol. 2020 Sep 15;883:1 – 10
Minuljo TT, Anindita YPC. Karakteristik dan Keluaran Pasien COVID-19 dengan DM di RS Umum Pusat Dr. Kariadi. Med Hosp. 2020 Agst;7(1A):150 – 158
Cibro AAL, Skripsiana NS, Muthmainah N. Gambaran Karakteristik dan Penyakit Komorbid pada Pasien Konfirmasi COVID-19 di RSUD Ulin Banjarmasin Tahun 2020. Homeostasis. 2022 Apr ;5(1):11–8
Khaerunnisa R, Rumana NA, Yulia N, Fannya P. Gambaran Karakteristik Pasien Covid-19 di Rumah Sakit Mekar Sari Bekasi Tahun 2020-2021. Jurnal Manajemen Informasi Kesehatan Indonesia. 2022 Mar;10(1):64 – 72.
Drew C, Adisasmita AC. Gejala Dan Komorbid Yang Memengaruhi Mortalitas Pasien Positif COVID-19 Di Jakarta Timur, Maret-September 2020. Tarumanagara Medical Journal. 2021 Apr;3(1):42–51
Indriyani N, Sabri YS, Afriani A. Association Between Comorbidities and Outcome of COVID-19 Patients at dr. M. Djamil General Hospital Padang. Respiratory Science. 2022 Sept;3(1):38 – 50.
